ZBIO
Zenas BioPharma, Inc.
28.70
+0.12 (+0.42%)
52w low 13.50
44.60 high
48.9% of range
Financial Analysis
| (USD) | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|---|---|
| Total Revenue | -- | 0.00 | 0.00 | 0.00 | 1.00M | 10.00M | |
| Operating Expenses | -- | 47.58M | 71.31M | 77.35M | 78.66M | 85.91M | |
| R&D | -- | 34.40M | 55.72M | 60.44M | 62.91M | 58.47M | |
| SG&A | -- | 13.18M | 15.59M | 16.91M | 15.75M | 27.43M | |
| Operating Income | -- | -47.58M | -71.31M | -77.35M | -77.66M | -75.91M | |
| EBITDA | -- | -49.81M | -230.41M | -74.35M | -101.04M | -97.65M | |
| Pretax Income | -- | -51.50M | -240.34M | -80.99M | -111.34M | -108.87M | |
| Income Tax | -- | 0.00 | 106.00K | 0.00 | 114.00K | 49.00K | |
| Net Income | -- | -51.50M | -240.44M | -80.99M | -111.46M | -108.92M | |
| EPS Diluted | -- | -1.22 | -4.54 | -1.46 | -1.77 | -1.65 | |
| Diluted Shares | -- | 42.16M | 53.00M | 55.62M | 63.11M | 66.15M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+900.0%